A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis
Elliot M. Frohman, Gary Cutter, Hongjiang Gao, Amber Salter, Gina Remington, Amy Conger, Katherine Treadaway, Teresa C. Frohman, Angela Bates, Olaf Stuve, Benjamin M. Greenberg, Howard Rossman, Bianca Weinstock Guttman, Eric Lindzen, Jacqueline E. Durfee, Ellen Carl, Michael G. Dwyer, Anjali Shah, Jennifer L. Cox, Michael K. RackeRobert Zivadinov
Dive into the research topics of 'A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.